Older Adults With Brain-Clogging Plagues Experience Early Stage Of Alzheimer’s Disease, New Study Confirms By Carie P. firstname.lastname@example.org | Jun 14, 2017 06:15 PM EDT A recent study just proved that older adults with a high level of brain-clogging plagues are most likely to experience the early stage of Alzheimer's disease. It was found out that this serves as the precursor before the actual symptom will be felt. In a new research conducted by a group of experts at the Keck School of Medicine of USC, it was found out that older adults who have this precursor will experience a faster mental decline. This will be the start of the early stage of the Alzheimer's disease as claimed by the result of the study. It was also revealed on Medical Express that the amyloid plagues are considered as a risk factor for Alzheimer's as it also showed that the presence of sticky and toxic protein will trigger the disease. Therefore, in order to deal with the disease effectively, medical experts need to find ways to intervene against amyloid. Watch video The treatment and elimination of this amyloid should be quick as this leads to the development of the Alzheimer's. Through the study, it was then claimed that the increased amyloid levels are actually an early stage already of the disease. Because of this, the researchers recommended for an anti-amyloid therapy if the Alzheimer's disease needs to be treated immediately and to prevent the worsening of it. The said research also paved the way to the idea that the disease actually begins before the symptoms are felt and experienced. The result of the study was also beneficial for experts in treating Alzheimer's disease in laying down the plan or an appropriate early intervention. The amyloid was also likened to cholesterol in the blood which is both warning signs with little or no manifestations at all. Since the amyloid plague is already the precursor before the early stage of the Alzheimer's disease, it will be best if there is a powerful approach to treating this. With this, the removal of the amyloid at the preclinical stage will slow or even stop the disease.